New Drug's first human test: is it safe?
NCT ID NCT07184606
Summary
This is a very early study to check the safety of a new drug called Fluorothiazinone and see how the body processes it. It will involve 70 healthy adult volunteers. Researchers will first give single doses to small groups, watching for side effects, before testing a repeated dose schedule.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SAFETY AND PHARMACOKINETICS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.